Barclays
RGEN icon

Barclays’s Repligen RGEN Stock Holding History

Barclays’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.9M Buy
194,016
+34,864
+22% +$4.87M 0.01% 1038
2025
Q4 		$26.1M Sell
159,152
-97,690
-38% -$15.3M 0.01% 1092
2025
Q3 		$34.3M Buy
256,842
+184,787
+256% +$22.4M 0.01% 943
2025
Q2 		$8.96M Buy
72,055
+31,166
+76% +$3.97M ﹤0.01% 1661
2025
Q1 		$5.2M Sell
40,889
-46,874
-53% -$7.22M ﹤0.01% 1878
2024
Q4 		$12.6M Buy
87,763
+61,368
+232% +$8.8M ﹤0.01% 1393
2024
Q3 		$3.93M Sell
26,395
-60,761
-70% -$8.71M ﹤0.01% 2286
2024
Q2 		$11M Sell
87,156
-42,395
-33% -$6.64M ﹤0.01% 1155
2024
Q1 		$23.8M Buy
129,551
+15,380
+13% +$2.93M 0.01% 912
2023
Q4 		$20.5M Buy
114,171
+36,810
+48% +$5.73M 0.01% 1038
2023
Q3 		$12.3M Sell
77,361
-7,035
-8% -$1.15M 0.01% 911
2023
Q2 		$11.9M Buy
84,396
+5,838
+7% +$936K 0.01% 916
2023
Q1 		$13.2M Buy
78,558
+29,387
+60% +$5.24M 0.01% 1046
2022
Q4 		$8.33M Buy
49,171
+22,591
+85% +$4.1M ﹤0.01% 1302
2022
Q3 		$4.97M Buy
26,580
+2,188
+9% +$461K 0.01% 1168
2022
Q2 		$3.96M Buy
24,392
+10,024
+70% +$1.59M ﹤0.01% 1460
2022
Q1 		$2.7M Buy
14,368
+1,168
+9% +$222K ﹤0.01% 1642
2021
Q4 		$3.5M Sell
13,200
-22,974
-64% -$6.19M ﹤0.01% 1972
2021
Q3 		$10.5M Sell
36,174
-2,988
-8% -$767K ﹤0.01% 1173
2021
Q2 		$7.82M Buy
39,162
+22,565
+136% +$4.38M ﹤0.01% 1323
2021
Q1 		$3.23M Sell
16,597
-26,505
-61% -$5.43M ﹤0.01% 1884
2020
Q4 		$8.26M Buy
43,102
+5,813
+16% +$1.06M ﹤0.01% 1246
2020
Q3 		$5.5M Sell
37,289
-12,386
-25% -$1.77M ﹤0.01% 1340
2020
Q2 		$6.14M Buy
49,675
+82
+0.2% +$9.65K ﹤0.01% 1220
2020
Q1 		$4.79M Sell
49,593
-28,012
-36% -$2.7M ﹤0.01% 1508
2019
Q4 		$7.18M Buy
77,605
+42,843
+123% +$3.6M ﹤0.01% 1660
2019
Q3 		$2.67M Sell
34,762
-18,039
-34% -$1.58M ﹤0.01% 2512
2019
Q2 		$4.54M Buy
52,801
+19,917
+61% +$1.36M ﹤0.01% 1955
2019
Q1 		$1.94M Buy
32,884
+12,703
+63% +$730K ﹤0.01% 2602
2018
Q4 		$1.06M Sell
20,181
-24,791
-55% -$1.45M ﹤0.01% 3046
2018
Q3 		$2.49M Buy
44,972
+29,318
+187% +$1.51M ﹤0.01% 2620
2018
Q2 		$736K Buy
15,654
+1,739
+12% +$71.6K ﹤0.01% 3577
2018
Q1 		$504K Buy
13,915
+7,949
+133% +$280K ﹤0.01% 3967
2017
Q4 		$216K Buy
5,966
+220
+4% +$7.96K ﹤0.01% 4621
2017
Q3 		$219K Sell
5,746
-3,915
-41% -$164K ﹤0.01% 4352
2017
Q2 		$401K Sell
9,661
-888
-8% -$33.7K ﹤0.01% 3730
2017
Q1 		$371K Buy
10,549
+3,864
+58% +$122K ﹤0.01% 3705
2016
Q4 		$206K Buy
6,685
+5,434
+434% +$168K ﹤0.01% 4196
2016
Q3 		$38K Buy
1,251
+1,021
+444% +$30.8K ﹤0.01% 5142
2016
Q2 		$6K Sell
230
-1,210
-84% -$30.9K ﹤0.01% 5711
2016
Q1 		$37K Sell
1,440
-1,414
-50% -$34.6K ﹤0.01% 4943
2015
Q4 		$80K Sell
2,854
-6,132
-68% -$177K ﹤0.01% 4544
2015
Q3 		$243K Buy
8,986
+8,351
+1,315% +$302K ﹤0.01% 3994
2015
Q2 		$26K Sell
635
-8,276
-93% -$303K ﹤0.01% 5524
2015
Q1 		$269K Buy
8,911
+5,209
+141% +$135K ﹤0.01% 4119
2014
Q4 		$70K Sell
3,702
-5,764
-61% -$129K ﹤0.01% 5459
2014
Q3 		$180K Buy
9,466
+2,756
+41% +$58K ﹤0.01% 4834
2014
Q2 		$148K Buy
6,710
+2,415
+56% +$43K ﹤0.01% 5120
2014
Q1 		$52K Buy
4,295
+1,526
+55% +$21.9K ﹤0.01% 5963
2013
Q4 		$36K Sell
2,769
-12,284
-82% -$147K ﹤0.01% 6402
2013
Q3 		$165K Sell
15,053
-907
-6% -$9.03K ﹤0.01% 5212
2013
Q2 		$131K Buy
+15,960
New +$134K ﹤0.01% 5566

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Barclays's RGEN Position: Q1 2026 in Review

Barclays increased its Repligen (RGEN) stake by 22% in Q1 2026, buying an estimated $4.87M and bringing the position to 194,016 shares worth $22.9M. The position accounts for 0.01% of the portfolio, ranked #1038.

Barclays first reported a position in RGEN in Q2 2013 and has held it in 52 quarters since. The position peaked at $34.3M in Q3 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Barclays held 194,016 shares of Repligen worth $22.9M as of Q1 2026.
  • Barclays bought 34,864 Repligen shares in Q1 2026, an estimated $4.87M.
  • Repligen made up 0.01% of Barclays's portfolio in Q1 2026, its #1038 holding.
  • Barclays first reported a position in Repligen in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Repligen position peaked at $34.3M in Q3 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.